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Abstract
Many commercially available recombinant proteins are produced in Escherichia
coli, and most suppliers guarantee contamination levels of less than 1 endotoxin
unit (EU). When we analysed commercially available proteins for their endotoxin
content, we found contamination levels in the same range as generally stated in the
data sheets, but also some that were higher. To analyse whether these low levels of
contamination have an effect on immune cells, we stimulated the monocytic cell line
THP-1, primary human monocytes, in vitro differentiated human monocyte-derived
dendritic cells, and primary human CD1c+ dendritic cells (DCs) with very low
concentrations of lipopolysaccharide (LPS; ranging from 0.002–2 ng/ml). We show
that CD1c+ DCs especially can be activated by minimal amounts of LPS, equivalent
to the levels of endotoxin contamination we detected in some commercially
available proteins. Notably, the enhanced endotoxin sensitivity of CD1c+ DCs was
closely correlated with high CD14 expression levels observed in CD1c+ DCs that
had been maintained in cell culture medium for 24 hours. When working with cells
that are particularly sensitive to LPS, even low endotoxin contamination may
generate erroneous data. We therefore recommend that recombinant proteins be
thoroughly screened for endotoxin contamination using the limulus amebocyte
lysate test, fluorescence-based assays, or a luciferase based NF-kB reporter assay
involving highly LPS-sensitive cells overexpressing TLR4, MD-2 and CD14.
Introduction
Many commercially available recombinant proteins, especially small and non-
glycosylated proteins, are produced in Escherichia coli (E.coli). Although this
expression system has many advantages, including rapid expression, high yields,
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ease of culture and low cost [1], the proteins recovered may be contaminated by
endotoxin. This highly complex lipopolysaccharide (LPS) is a major component
of the outer membrane of most gram-negative bacteria and is regarded as the
main virulence factor of the latter [2]. LPS is recognized by a receptor complex
composed of TLR4, CD14 and MD-2 [3]. Upon recognition and binding of
microbial ligands by the extracellular domains of this receptor complex, the
intracellular portion recruits adaptor kinases which enable signal transduction,
most likely through activation of the transcription factor nuclear factor-kappa B
(NF-kB) [4, 5]. In human monocytes and macrophages these transcriptional
responses culminate in the release of pro-inflammatory cytokines, including
TNFa, IL-1b, IL-6, IL-8, and IL-12 [6, 7].
In data sheets accompanying commercially produced recombinant proteins, the
amount of bacterial contamination is usually stated in endotoxin units (EU), and
most suppliers guarantee contamination levels of less than 1 EU, which is
approximately equivalent to 100 pg of E. coli LPS per microgram of recombinant
protein [8]. Based on that level, protein preparations at concentrations ranging
from 10–1000 ng/ml may be contaminated with 1-100 pg LPS. Because the vast
majority of in vitro studies have reported on endotoxin effects induced by
concentrations between 1 and 100 ng/ml, the current study investigates the effects
of very low endotoxin concentrations ranging from 0.002–2 ng/ml on human
immune cells, as these concentrations are equivalent to the amount of residual
contamination present in recombinant proteins.
Materials and Methods
All studies involving human cells were conducted in accordance with the
guidelines of the World Medical Association’s Declaration of Helsinki.
Isolation and cultivation of cells and cell lines
THP-1 cells were cultivated in RPMI 1640 medium (Sigma-Aldrich, Vienna,
Austria) supplemented with 10% heat-inactivated (i.a.) fetal bovine serum (FBS;
PAA, GE Healthcare, Pasching, Austria), 100 U/ml penicillin (PAA), 100 mg/ml
streptomycin (PAA) and 2 mM L-glutamine (Gibco, Life Technologies, Lofer,
Austria).
Monocytes and moDCs were generated from buffy coats from healthy,
anonymous donors (provided by the blood bank Salzburg, Austria) using the
adherence method as described before [9]. Briefly, peripheral blood mononuclear
cells (PBMCs) were isolated from buffy coats by gradient centrifugation using
Ficoll-Paque PLUS (PAA, GE Healthcare, Pasching, Austria). After erythrocyte
lysis using ACK buffer (150 mM ammonium chloride, 10 mM potassium
bicarbonate, 0.1 mM EDTA) and extensive washing with RPMI 1640 medium,
cells were left to adhere for 90 min at 37 C˚ and 5% CO2 in six-well plates in RPMI
1640 medium containing 10% i.a. FBS, 100 U/ml penicillin, 100 mg/ml
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streptomycin, 2 mM L-glutamine and 50 mM 2-mercaptoethanol. Non-adherent
cells were then removed by extensive washing using warm RPMI 1640 medium.
For the generation of moDCs, adherent monocytes were stimulated with 50 ng/ml
GM-CSF and 50 ng/ml IL-4 (kind gifts from Novartis, Vienna, Austria) for six
days. At day 3, 1 vol of the supplemented medium containing fresh cytokines was
added.
Primary human CD1c+ DCs were isolated via magnetic cell sorting using the
Miltenyi CD1c (BCDA-1) + Dendritic Cell Isolation Kit according to the
manufacturer’s instructions. CD1c+ DCs were cultivated in DC-medium (RPMI
1640 medium supplemented with 10% i.a. FBS, 100 U/ml penicillin, 100 mg/ml
streptomycin and 2 mM L-glutamine). The purity of monocytes, moDCs and
CD1c+ DCs was routinely analysed by flow cytometry.
Reagents and recombinant proteins
E. coli LPS 055:B5 was obtained from Sigma–Aldrich, Vienna, Austria. All proteins
tested in this study are recombinant human cytokines and were obtained from
three different suppliers, labelled supplier 1, 2 and 3. According to the
manufacturers’ data sheets, these recombinant proteins were routinely tested for
endotoxin contamination by unspecified LAL tests. However, we do not disclose
the names of the manufacturers or products in this study due to the proprietary
nature of this information.
EndoZyme and EndoLISA
The EndoZyme and EndoLISA endotoxin detection assays were purchased from
Hyglos GmbH, Bernried am Starnberger See, Germany and performed according
to the manufacturer’s instructions. Fluorescence was measured using a Tecan
Infinite 200 Pro microplate reader. The sensitivity setting (gain) of the
fluorescence reader was adjusted by performing the assays one time at
automatically detected optimal gain at the 90 min timepoint. This gain setting was
then used throughout all further experiments. Standard curves were calculated
using a non-linear regression model.
Transfection of HEK293 cells and luciferase assay
1.26105 HEK293 cells per well in 500 ml antibiotics-free DMEM medium (Sigma-
Aldrich; supplemented with 10% i.a. FBS, 2 mM L-glutamine and 2 mM MEM
non-essential amino acids) were plated in 24-well plates. After 24 h, cells were
transfected using Lipofectamine 2000 reagent (Invitrogen, Life Technologies,
Lofer, Austria) according to the manufacturer’s instructions. Briefly, per well,
500 ng DNA and 1.5 ml of Lipofectamine 2000 reagent were diluted in 25 ml of
Opti-MEM (Gibco). As DNA, an NF-kB Luciferase reporter (kindly provided by
Min Li-Weber [10] and cloned into pGL3Neo in our laboratory) and a TLR4-
CD14-MD2 mix was used in a ratio of 4:1. The mix consists of expression
plasmids for TLR4 (in pCDNA3), CD14 (in pCDNA3) and MD-2 (in pEFBOS)
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(kind gifts from Andrei Medvedev and Douglas Golenbock) in a ratio of 3:1:1.
Both reactions were mixed, pooled and incubated for 5 min at room temperature
(RT). The transfection mix was then added to the wells. After 24 h, the medium
was replaced with fresh medium (DMEM supplemented with 10% i.a. FBS, 2 mM
L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and 1x MEM (2 mM)
non-essential amino acids). Cells were then induced with the appropriate stimuli.
After 20 h of induction, supernatants were discarded and 100 ml of lysis buffer
(100 mM potassium phosphate, 0.1% Triton X-100, 1 mM DTT) was added to
each well. The lysates were transferred to white polystyrene flat-bottom microtitre
plates in duplicates. Luciferase activity was measured in a Tecan Infinite 200 Pro
microplate reader, where 50 ml of luciferase substrate was added using an
automated dispenser.
Limulus amebocyte lysate (LAL) assay
The Pyrotell-T (Cape Cod, MA, USA) LAL-assay was used according to the
manufacturer’s instructions. Turbidity was measured every 10 min for at least
1.5 h at 37 C˚ in a Tecan Infinite 200 Pro microplate reader at 405 nm. The time
point with the highest resolution between the endotoxin standard samples was
chosen for analysis.
Enzyme-linked immunosorbent assay (ELISA)
The human IL-1b DuoSet ELISA kit was purchased from R&D Systems,
Biomedica, Vienna, Austria. All other ELISA kits were purchased from Peprotech,
Vienna, Austria. The assays were performed according to the manufacturers’
instructions. Briefly, NUNC MaxiSorp flat-bottom 96-well plates (eBioscience,
Affymetrix, Vienna, Austria) were coated with a capture antibody overnight and
blocked with PBS containing 1% bovine serum albumin (BSA) for 1 h. After
washing, cell supernatants were added and incubated for at least 2 h at room
temperature (RT). Plates were washed again and the biotinylated detection
antibody was added. After incubation for 1 h at RT, plates were again washed and
avidin-conjugated horseradish peroxidase was added. After 30 min of incubation
and another washing step, the substrate (TMB from Sigma-Aldrich) was added.
The reaction was stopped by adding 2 M sulphuric acid. Colour intensity was
measured at 450 nm and a reference wavelength of 650 nm was subtracted. The
respective standards were used to calculate total protein concentrations.
Quantitative real-time PCR (qRT-PCR)
Total RNA from cells was isolated using TRI reagent (Sigma-Aldrich) and reverse
transcribed with RevertAid H Minus reverse transcriptase (Thermo Scientific,
Vienna, Austria) according to the manufacturer’s instructions. Quantitative real-
time RT-PCR (qRT-PCR) was performed on a Rotorgene 3000 (Corbett Research,
Mortlake, Australia) using iQ SYBR Green Supermix (Bio-Rad, Vienna, Austria)
and the primers listed below. The large ribosomal protein P0 (RPLP0) was used as
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a reference. Specificity was controlled by recording a melting curve for the PCR
products. Relative mRNA expression levels were calculated using the formula
x522DCt, where Ct represents the threshold cycle of a given gene and DCt signifies
the difference between the Ct values of the gene in question and the Ct value of
the reference gene.
Primer sequences:
Human IL-1b sense 59-GTA CCT GAG CTC GCC AGT GA-39 and anti-sense
59-TCG GAG ATT CGT AGC TGG ATG-39.
Human RPLP0 sense 59-GGC ACC ATT GAA ATC CTG AGT GAT GTG-39
and anti-sense 59-TTG CGG ACA CCC TCC AGG AAG-39.
Flow cytometry
For flow cytometry, 16105 cells were suspended in 50 ml of ice-cold FACS buffer
(PBS supplemented with 3% i.a. FBS) including appropriate amounts of
fluorescent-labelled antibodies. As a control for nonspecific binding, one aliquot
of cells was labelled with isotype-specific control antibodies in excess concentra-
tion. Cells were analysed using a FACS Canto II flow cytometer (BD Biosciences).
Primary monocytes, moDCs and CD1c+ DCs were gated according to cell-specific
surface markers (CD14, CD1a and CD1c, respectively). For analysis of CD40,
CD80, CD83 and CD86 surface expression, the median fluorescence intensity
(MFI) of 16104 cells was recorded for every sample. The fold-changes of the MFIs
were then calculated compared to the control cells (PBS/BSA-induced cells) of
each cell type, to allow direct comparison of the different cell types measured with
different voltages and/or compensation settings. For analysis of TLR4 and CD14
surface expression, cells were gated according to the individual isotype controls,
and the percentages of TLR4 and CD14 positive cells were used as readout. For
statistical analysis, an ANOVA with a Dunnett post-test was performed for each
cell type individually, using the MFI values (not the fold-change values), or the
percentages of positive cells. Anti-human CD1c-FITC and mouse IgG1-PE isotype
control were obtained from BioLegend, Vienna, Austria. Anti-human CD1a-
FITC, CD14-FITC, CD14-PE, CD19-PE, mouse IgG1-FITC, mouse IgG2a-APC
and mouse IgG2b-PE isotype controls were purchased from Immunotools,
Vienna, Austria. Anti-human CD14-APC, CD1a-APC, mouse IgG1-FITC isotype
control, CD40-APC, CD80-PE, CD83-APC and CD86-PE were acquired from BD
Biosciences, Erembodegem, Belgium. Anti-human CD1c-APC and mouse IgG1-
APC isotype control were purchased from R&D Systems, and anti-human TLR4
(CD284)-Alexa Fluor 488 was obtained from eBioscience.
Results
To assess whether LPS levels in the range of 0.1–1 EU are actually present in
commercial recombinant proteins, we performed LAL assays on five commercially
obtained recombinant proteins. As shown in Table 1, three proteins had a slightly
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higher endotoxin amount than stated in the data sheet. Of note, the measured
endotoxin levels in recombinant protein 1, a product that was obtained from two
different suppliers, were vastly different. Whereas the protein from supplier 2 had
barely measurable endotoxin impurities (2 pg/mg protein), the product from
supplier 1 was contaminated with 140 pg of endotoxin per microgram of protein,
somewhat higher than the maximum specified by the manufacturer (,1 EU or
,100 pg). To confirm these endotoxin contaminations, recombinant protein 1
from both suppliers was once more tested by alternative endotoxin detection
assays (EndoZyme and EndoLISA) along with increasing concentrations of LPS (
Figure 1). The two additional assays revealed detectable endotoxin contamina-
tions for protein 1 from supplier 1, although the results provided by the three
different assays (LAL, EndoZyme and EndoLISA) were not completely identical
and ranged between 0.8 and 1.4 EU.
To assesses whether these small amounts of LPS are capable of activating NF-
kB-signalling, we generated a highly LPS-responsive cell system modified from
Peters and colleagues [11] by co-transfecting HEK293 cells with expression
plasmids encoding the LPS receptor subunits TLR4, CD14 and MD-2 along with
an NF-kB luciferase reporter plasmid. These cells were exposed to different
concentrations of recombinant protein 1 from suppliers 1 and 2, as well as to
different amounts of LPS. As shown in Figure 2, the recombinant protein from
supplier 1 induced an increase in NF-kB activity, whereas the protein from
supplier 2 did not activate NF-kB (even at 400 ng/ml, twice as high as the
maximum protein concentration tested from supplier 1). Interestingly, the
protein from supplier 1 induced NF-kB activation in the same range as 0.02 ng/ml
LPS. Of note, this LPS concentration is approximately equivalent to the amount
of contamination in 100 ng of recombinant protein, as measured in the LAL test
above. This experiment clearly shows that even the small amounts of endotoxin
contamination found in commercially available recombinant proteins are
sufficient to activate NF-kB in a highly sensitive cell system.
Because transfected HEK293 cells are a rather artificial cell model, we tested
different human immune cells that are naturally sensitive to endotoxins: we
stimulated the monocytic cell line THP-1, primary monocytes, in vitro
Table 1. Measured impurities in protein preparations from different suppliers evaluated by LAL tests.
Impurities according to datasheet Impurities according to LAL Test Impurities at 100 ng protein
PBS/0.1% BSA - ,0.1 EU -
DC Medium without FBS - ,0.1 EU -
DC Medium with 10% i.a. FBS - ,0.1 EU -
Recombinant protein 1, supplier 1 ,1 EU (,0.1 ng/mg protein) 1.4 EU (0.14 ng/mg protein) 0.014 ng
Recombinant protein 1, supplier 2 ,1 EU (,0.1 ng/mg protein) ,0.1 EU (0.01 ng/mg protein) ,0.001 ng
Recombinant protein 2, supplier 1 ,0.1 EU (,0.01 ng/mg protein) 0.32 EU (0.032 ng/mg protein) 0.003 ng
Recombinant protein 3, supplier 1 ,0.1 EU (,0.01 ng/mg protein) 0.25 EU (0.025 ng/mg protein) 0.003 ng
Recombinant protein 4, supplier 3 ,1 EU (,0.1 ng/mg protein) ,0.1 EU (0.01 ng/mg protein) ,0.001 ng
doi:10.1371/journal.pone.0113840.t001
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differentiated monocyte-derived dendritic cells (moDCs), and primary CD1c+
dendritic cells (CD1c+ DCs) with very low LPS concentrations. As shown in
Figure 3A, even 0.02 ng/ml LPS was able to significantly stimulate the production
of cytokines. However, we observed some vast differences between the individual
cell types in terms of both the types of cytokines they produced and their
sensitivity to LPS. THP-1 cells produced only minuscule amounts of IL-8 upon
stimulation with the highest LPS-concentration used (2 ng/ml), whereas moDCs
secreted considerable amounts of IL-6, IL-8, TNF-a and IL-12 at the same high
LPS concentration. In contrast, human monocytes and CD1c+ DCs were much
more sensitive to LPS, as 0.2 ng/ml LPS was sufficient to induce the release of all
tested cytokines, except for IL-12 in monocytes. One important observation in
this context is that, in both monocytes and CD1c+ DCs, statistically significant
amounts of IL-8 were measured in response to 0.02 ng/ml LPS. Moreover, CD1c+
DCs additionally produced IL-6 upon activation under these conditions. In
Figure 1. Analysis of endotoxin contents by two commercially available endotoxin detection assays.
Endotoxin contamination levels of recombinant protein 1 from suppliers 1 and 2 were measured by EndoZyme
and EndoLISA. Results show impurities in 1 mg of recombinant protein 1 from two different suppliers
(rec.prot.1 suppl.1 and rec.prot.1 suppl.2). As controls, total amounts of 0.001–2 ng E.coli LPS, as well as
solvent (PBS containing 0.1% BSA, undiluted), DC-medium without FBS (Med –FBS) and with FBS (Med +
FBS; both diluted 1:10 in endotoxin-free water) were used. Results show mean values of technical duplicates.
n.d., not detectable; n.a., not applicable.
doi:10.1371/journal.pone.0113840.g001
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contrast, significant release of IL-1b was observed only from monocytes treated
with 2 ng/ml LPS, whereas lower LPS concentrations had no significant effect, and
none of the other cells types secreted IL-1b in our experimental setup (Figure 3B,
left panel). IL-1b is expressed as a biologically inactive 31-kDa pro-form that
requires post-translational processing by caspase-1 to generate the biologically
active cytokine IL-1b [12, 13]. To investigate whether low LPS concentrations
would stimulate the post-translational processing of pro-IL-1b or rather induce
IL-1b expression at the transcriptional level, we analysed IL-1b mRNA after
6 hours of LPS stimulation (Figure 3, B right panel). As IL-1b mRNA expression
directly correlates with IL-1b secretion, we assume that low LPS concentrations
regulate IL-1b secretion at the transcriptional rather than the post-translational
level.
To investigate whether stimulation of different immune cells with minimal LPS
concentrations would also result in the up-regulation of typical co-stimulatory
molecules, we analysed the surface expression of CD40, CD80, CD83 and CD86 by
flow cytometry (Figure 4). Again, THP-1 cells were the least sensitive cell type and
required 2 ng/ml LPS to show minor changes in surface marker expression.
Similar to our observations with cytokine secretion, moDCs required 2 ng/ml LPS
to induce expression of all activation markers as well, but the changes in surface
marker expression were again of much higher significance than in THP-1 cells.
Whereas monocytes are highly sensitive to LPS and showed up-regulation of
CD40 and CD80 in response to 0.02 ng/ml LPS, CD1c+ DCs seem to be even more
Figure 2. Activation of NF-kB by endotoxin impurities in commercial preparations of a recombinant protein. NF-kB activation in HEK293 cells
transfected with an NF-kB luciferase reporter plasmid and plasmids encoding LPS-receptor components (TLR4, CD14, MD-2) is shown. Cells were exposed
to recombinant protein 1 from supplier 1 or 2, LPS, or solvent, in the amounts stated. 20 h after induction, luciferase activity was measured. Results show
mean and standard deviations of four independent experiments.
doi:10.1371/journal.pone.0113840.g002
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sensitive, as they additionally expressed CD86 at these minimal LPS concentra-
tions.
Binding of LPS brings CD14, MD-2 and TLR4 in close proximity, thereby
forming the LPS receptor complex [4]. Formation and activation of this complex
Figure 3. Effects of low LPS concentrations on cytokine production in different human immune cells. A 16105 THP-1 cells, primary human
monocytes, monocyte-derived DCs (moDCs), or CD1c+ DCs were either stimulated with different concentrations of LPS or solvent (PBS/BSA) as a control.
After 16 h, supernatants were harvested and analysed by ELISA. Results show means and SD of at least four independent experiments per cell type. B Left
panel: Cells were plated and stimulated as described above. After 24 h, supernatants were harvested and analysed for IL-1b expression by ELISA. Results
show means and SD of at least five independent experiments per cell type. Right panel: 16105 monocytes were stimulated as described above. After 6 h,
cells were harvested and mRNA levels were measured by qRT-PCR. Results show means and SD of three independent experiments. One-way ANOVA with
a Dunnett post-test was performed for each cell type individually. * p,0.05, ** p,0.01, *** p,0.001 compared to the solvent control of the respective cell
type.
doi:10.1371/journal.pone.0113840.g003
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results in docking of different adapter molecules, which induces a first wave of
NF-kB activation [5, 14]. Whereas CD14 binds the carbohydrate portion of LPS
and is thus mainly involved in LPS recognition [15], TLR4 acts as the main
signalling receptor for LPS [16]. To analyse whether the high LPS sensitivity of
monocytes and especially CD1c+ DCs was related to the expression of CD14 and/
or TLR4, we compared the expression of both surface molecules on all four cell
types. Whereas in monocytes and CD1c+ DCs TLR4 is hardly detectable, a major
fraction of both cell types expresses CD14, which is significantly down-regulated
with increasing concentrations of LPS. In contrast, THP1 cells and moDCs express
TLR4 on their surface, but lack substantial CD14 expression (Figure 5A).
Although a minor population of freshly isolated, blood-derived human CD1c+
DCs was previously shown to express CD14 [17, 18], the high number of CD14-
expressing CD1c+ DCs observed in our experimental setup was rather unexpected.
Because we monitored CD14 expression 24 h after cell isolation, we cultured
CD1c+ DCs in medium for 24 h and compared CD14 expression to cells that have
been freshly isolated. In line with previous studies [17, 18], only a minor fraction
of CD1c+ DCs was found to express CD14 immediately after cell isolation,
Figure 4. Surface marker expression upon stimulation with low LPS concentrations. Cells were plated and induced as described in Figure 3. After
16 h of induction, cells were harvested and stained for the expression of surface markers using appropriate amounts of fluorescent-labelled antibodies. The
median of the fluorescence intensities of 16104 cells each was recorded by flow cytometry. Fold change values were calculated to compare individual cell
types with different compensation settings. Results show mean and SD of at least four independent experiments per cell type. Statistical analysis was
performed as described in Figure 3.
doi:10.1371/journal.pone.0113840.g004
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Figure 5. Endotoxin sensitivity correlates with CD14 expression. A Expression of TLR4 and CD14 on
different human immune cells. Cells were plated and induced as described in Figure 3. After 24 h, cells were
stained for the expression of TLR4 and CD14 and analysed by flow cytometry. Results show the percentage
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whereas CD14 expression was drastically increased after culturing the cells in DC-
medium for 24 h (Figure 5B).
Discussion
The present study aimed at investigating the effects of very low LPS
concentrations on human immune cells. We show that CD1c+ dendritic cells
especially can be activated by minimal amounts of LPS, equivalent to the levels of
endotoxin contamination we detected in some commercially available proteins.
THP-1 cells were the least sensitive cell type, which might be explained by the fact
that they represent a relatively immature type in the monocyte-macrophage cell
lineage that expresses low levels of CD14 [19]. As CD14-deficient monocytes are
characterised by poor LPS uptake [20], low CD14 expression in THP-1 cells could
result in reduced sensitivity to LPS. Although CD14+ monocytes have been used as
precursors for the generation of moDCs, the latter have a typical DC-like
morphology. moDCs express high levels of CD1a but lack CD14 [21], which may
again account for the lower LPS sensitivity of these cells compared to monocytes.
Interestingly, CD1c+ DCs are classified as myeloid DCs, the majority of which are
CD142 [22]. Yet, a minor fraction of these cells was previously described to
express CD14 [17, 18]. In the present study we clearly show that CD1c+ DCs
maintained in cell culture medium for 24 hours express increased levels of CD14.
CD14 was shown to bind LPS at picomolar concentrations and to be critically
involved in controlling endotoxin sensitivity especially to low concentrations of
LPS [23, 24]. We therefore assume that the high CD14 expression on CD1c+ DCs
observed after 24 hours of culturing significantly contributes to the enhanced
sensitivity of these cells and allows for LPS-induced cytokine secretion and surface
marker expression, despite the fact that TLR4 expression is rather low in those
cells. However, besides CD14, other proteins as well, including LPS-binding
protein, the secreted glycoprotein MD-2 and a number of adaptor proteins,
contribute to LPS binding and LPS-induced signal transduction [4] and may thus
be important candidates for further investigation.
In conclusion, we showed that primary human immune cells, especially CD1c+
DCs, are highly sensitive to LPS and can be activated by LPS concentrations as low
as 0.02 ng/ml. This observation is of high significance because 0.02 ng LPS is
equivalent to the amount of endotoxin impurities that may be present in 100 ng
recombinant protein. Hence, the amounts of endotoxin impurities found in
commercially available recombinant proteins might be sufficient to activate
immune cells. Even if the LPS impurities alone do not affect those cells, it has to
of fluorescence-positive cells (% pos cells) compared to the respective isotype controls. Statistical analysis
was performed as described in Figure 3. B Analysis of CD1c, CD14 and CD19 expression on primary human
CD1c+ DCs. 16105 CD1c+ DCs were stained for the expression of CD1c, CD14 or CD19 either directly after
isolation (0 h), or after 24 h culture in 24-well plates containing 1 ml of DC-medium. Cells were then analysed
by flow cytometry. One representative donor is shown. Light grey, isotype control; dark grey, respective
surface marker staining.
doi:10.1371/journal.pone.0113840.g005
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be considered that low LPS concentrations together with other types of stimuli
(e.g. cytokines or NOD-like receptor ligands) could have synergistic effects [25–
27] and thus produce erroneous data. To avoid endotoxin contamination that
may compromise research experiments, we recommend working with proteins
that have been expressed under largely endotoxin-free conditions. This includes
either expression of recombinant proteins by non-bacterial expression systems like
HEK293 cells, or the use of a new line of competent cells called ClearColi, an E.
coli strain possessing a genetically modified LPS that does not induce
inflammatory responses in human cells. Although other potential bacterial
components (e.g. peptidoglycans or lipoproteins) may contaminate recombinant
proteins, LPS remains the main concern due to its heat stability [28], binding
affinity to different surfaces [29], and its ability to elicit immune responses at very
low concentrations [30]. Therefore, we strongly advise using the methods
mentioned in Table 1, Figure 1 and Figure 2 to ensure that all proteins used are
devoid of endotoxin impurities, especially when working with immune cells that
are highly sensitive to LPS.
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